323 related articles for article (PubMed ID: 11826410)
1. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.
Pagano G; Pacini G; Musso G; Gambino R; Mecca F; Depetris N; Cassader M; David E; Cavallo-Perin P; Rizzetto M
Hepatology; 2002 Feb; 35(2):367-72. PubMed ID: 11826410
[TBL] [Abstract][Full Text] [Related]
2. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.
Chitturi S; Abeygunasekera S; Farrell GC; Holmes-Walker J; Hui JM; Fung C; Karim R; Lin R; Samarasinghe D; Liddle C; Weltman M; George J
Hepatology; 2002 Feb; 35(2):373-9. PubMed ID: 11826411
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
[TBL] [Abstract][Full Text] [Related]
4. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis.
Musso G; Gambino R; De Michieli F; Cassader M; Rizzetto M; Durazzo M; Fagà E; Silli B; Pagano G
Hepatology; 2003 Apr; 37(4):909-16. PubMed ID: 12668986
[TBL] [Abstract][Full Text] [Related]
5. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis.
Bril F; Lomonaco R; Orsak B; Ortiz-Lopez C; Webb A; Tio F; Hecht J; Cusi K
Hepatology; 2014 Jun; 59(6):2178-87. PubMed ID: 24777953
[TBL] [Abstract][Full Text] [Related]
6. Acanthosis nigricans in patients with nonalcoholic steatohepatitis: an uncommon finding.
Uwaifo GI; Tjahjana M; Freedman RJ; Lutchman G; Promrat K
Endocr Pract; 2006; 12(4):371-9. PubMed ID: 16939948
[TBL] [Abstract][Full Text] [Related]
7. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis.
Musso G; Gambino R; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Cassader M; Durazzo M; Rizzetto M; Pagano G
Am J Gastroenterol; 2005 Nov; 100(11):2438-46. PubMed ID: 16279898
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.
Manco M; Marcellini M; Devito R; Comparcola D; Sartorelli MR; Nobili V
Int J Obes (Lond); 2008 Feb; 32(2):381-7. PubMed ID: 18087267
[TBL] [Abstract][Full Text] [Related]
9. [A study of the degrees of insulin resistance and first-phase insulin secretion of beta-cells in metabolic syndrome patients with different glucose tolerance].
Hong J; Gu WQ; Zhang YF; Guo Y; Chen HM; Zhang LZ; Zhao YJ; Ning G
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1952-6. PubMed ID: 14703429
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
Amoah AG; Owusu SK; Schuster DP; Osei K
S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome.
Setji TL; Holland ND; Sanders LL; Pereira KC; Diehl AM; Brown AJ
J Clin Endocrinol Metab; 2006 May; 91(5):1741-7. PubMed ID: 16492691
[TBL] [Abstract][Full Text] [Related]
12. Serum adipokine and ghrelin levels in nonalcoholic steatohepatitis.
Yalniz M; Bahcecioglu IH; Ataseven H; Ustundag B; Ilhan F; Poyrazoglu OK; Erensoy A
Mediators Inflamm; 2006; 2006(6):34295. PubMed ID: 17392582
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).
Hossain N; Stepanova M; Afendy A; Nader F; Younossi Y; Rafiq N; Goodman Z; Younossi ZM
Scand J Gastroenterol; 2011 Apr; 46(4):479-84. PubMed ID: 21114431
[TBL] [Abstract][Full Text] [Related]
14. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.
Neuschwander-Tetri BA; Brunt EM; Wehmeier KR; Oliver D; Bacon BR
Hepatology; 2003 Oct; 38(4):1008-17. PubMed ID: 14512888
[TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
Belfort R; Harrison SA; Brown K; Darland C; Finch J; Hardies J; Balas B; Gastaldelli A; Tio F; Pulcini J; Berria R; Ma JZ; Dwivedi S; Havranek R; Fincke C; DeFronzo R; Bannayan GA; Schenker S; Cusi K
N Engl J Med; 2006 Nov; 355(22):2297-307. PubMed ID: 17135584
[TBL] [Abstract][Full Text] [Related]
16. Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.
Chow WC; Tai ES; Lian SC; Tan CK; Sng I; Ng HS
Singapore Med J; 2007 Aug; 48(8):752-7. PubMed ID: 17657385
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis.
Musso G; Gambino R; Cassader M
J Nutr Biochem; 2010 Sep; 21(9):834-40. PubMed ID: 19733470
[TBL] [Abstract][Full Text] [Related]
18. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.
Chalasani N; Deeg MA; Persohn S; Crabb DW
Am J Gastroenterol; 2003 Aug; 98(8):1849-55. PubMed ID: 12907343
[TBL] [Abstract][Full Text] [Related]
20. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
